カテゴリー： 世界, 医療/バイオ, LP Information

世界のブタサーコウイルス2型（PCV2）ワクチン市場予測 2023年-2029年

【英語タイトル】Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08452）・商品コード：LP23DC08452
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のブタサーコウイルス2型（PCV2）ワクチン市場」は、過去の販売実績から2022年の世界のブタサーコウイルス2型（PCV2）ワクチンの総販売量を検討し、2023年から2029年の予測されるブタサーコウイルス2型（PCV2）ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のブタサーコウイルス2型（PCV2）ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界のブタサーコウイルス2型（PCV2）ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界のブタサーコウイルス2型（PCV2）ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のブタサーコウイルス2型（PCV2）ワクチン市場における各社の独自のポジションをより深く理解するために、ブタサーコウイルス2型（PCV2）ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のブタサーコウイルス2型（PCV2）ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ブタサーコウイルス2型（PCV2）ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ブタサーコウイルス2型（PCV2）ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ブタサーコウイルス2型（PCV2）ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ブタサーコウイルス2型（PCV2）ワクチンの世界主要メーカーとしては、Zoetis Animal Health、 Boehringer-Ingelheim、 Merck Animal Health、 Ceva Santé Animale、 MSD Animal Health、 SPAH、 Nanjing Tianbang Biological Technology、 Sichuan Huapai Bio-pharmaceutical、 Guangdong Winsun Bio Pharmaceutical、 Wuhan Keqian Biology、 Shanghai Hile Bio-Technology、 Harbin Pharmaceutical Group Bio-Vaccine、 Ringpu、 Shandong Huahong Bioengineering、 Weike Biotechnology、 Nanjing Tianbang Biological Technology、 China Animal Husbandry Industryなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のブタサーコウイルス2型（PCV2）ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではブタサーコウイルス2型（PCV2）ワクチン市場をセグメンテーションし、種類別 (WHタイプ、LGタイプ、SHタイプ、SDタイプ、ZJ Cタイプ、その他)、用途別 (子豚、成豚)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：WHタイプ、LGタイプ、SHタイプ、SDタイプ、ZJ Cタイプ、その他

・用途別区分：子豚、成豚

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のブタサーコウイルス2型（PCV2）ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見たブタサーコウイルス2型（PCV2）ワクチン市場成長の要因は何か？
・ブタサーコウイルス2型（PCV2）ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ブタサーコウイルス2型（PCV2）ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ブタサーコウイルス2型（PCV2）ワクチンの年間販売量2018-2029、地域別現状・将来分析
・ブタサーコウイルス2型（PCV2）ワクチンの種類別セグメント：WHタイプ、LGタイプ、SHタイプ、SDタイプ、ZJ Cタイプ、その他
・ブタサーコウイルス2型（PCV2）ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ブタサーコウイルス2型（PCV2）ワクチンの用途別セグメント：子豚、成豚
・ブタサーコウイルス2型（PCV2）ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のブタサーコウイルス2型（PCV2）ワクチン市場
・企業別のグローバルブタサーコウイルス2型（PCV2）ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のブタサーコウイルス2型（PCV2）ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別のブタサーコウイルス2型（PCV2）ワクチン販売価格
・主要企業のブタサーコウイルス2型（PCV2）ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ブタサーコウイルス2型（PCV2）ワクチンの地域別レビュー
・地域別のブタサーコウイルス2型（PCV2）ワクチン市場規模2018-2023：年間販売量、売上
・主要国別のブタサーコウイルス2型（PCV2）ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカのブタサーコウイルス2型（PCV2）ワクチン販売の成長
・アジア太平洋のブタサーコウイルス2型（PCV2）ワクチン販売の成長
・ヨーロッパのブタサーコウイルス2型（PCV2）ワクチン販売の成長
・中東・アフリカのブタサーコウイルス2型（PCV2）ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別のブタサーコウイルス2型（PCV2）ワクチン販売量、売上（2018-2023）
・南北アメリカのブタサーコウイルス2型（PCV2）ワクチンの種類別販売量
・南北アメリカのブタサーコウイルス2型（PCV2）ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のブタサーコウイルス2型（PCV2）ワクチン販売量、売上（2018-2023）
・アジア太平洋のブタサーコウイルス2型（PCV2）ワクチンの種類別販売量
・アジア太平洋のブタサーコウイルス2型（PCV2）ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のブタサーコウイルス2型（PCV2）ワクチン販売量、売上（2018-2023）
・ヨーロッパのブタサーコウイルス2型（PCV2）ワクチンの種類別販売量
・ヨーロッパのブタサーコウイルス2型（PCV2）ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のブタサーコウイルス2型（PCV2）ワクチン販売量、売上（2018-2023）
・中東・アフリカのブタサーコウイルス2型（PCV2）ワクチンの種類別販売量
・中東・アフリカのブタサーコウイルス2型（PCV2）ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ブタサーコウイルス2型（PCV2）ワクチンの製造コスト構造分析
・ブタサーコウイルス2型（PCV2）ワクチンの製造プロセス分析
・ブタサーコウイルス2型（PCV2）ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ブタサーコウイルス2型（PCV2）ワクチンの主要なグローバル販売業者
・ブタサーコウイルス2型（PCV2）ワクチンの主要なグローバル顧客

地域別のブタサーコウイルス2型（PCV2）ワクチン市場予測レビュー
・地域別のブタサーコウイルス2型（PCV2）ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ブタサーコウイルス2型（PCV2）ワクチンの種類別市場規模予測
・ブタサーコウイルス2型（PCV2）ワクチンの用途別市場規模予測

主要企業分析
Zoetis Animal Health、 Boehringer-Ingelheim、 Merck Animal Health、 Ceva Santé Animale、 MSD Animal Health、 SPAH、 Nanjing Tianbang Biological Technology、 Sichuan Huapai Bio-pharmaceutical、 Guangdong Winsun Bio Pharmaceutical、 Wuhan Keqian Biology、 Shanghai Hile Bio-Technology、 Harbin Pharmaceutical Group Bio-Vaccine、 Ringpu、 Shandong Huahong Bioengineering、 Weike Biotechnology、 Nanjing Tianbang Biological Technology、 China Animal Husbandry Industry
・企業情報
・ブタサーコウイルス2型（PCV2）ワクチン製品
・ブタサーコウイルス2型（PCV2）ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Porcine Circovirus Type 2 (PCV2) Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Porcine Circovirus Type 2 (PCV2) Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Porcine Circovirus Type 2 (PCV2) Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Porcine Circovirus Type 2 (PCV2) Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Porcine Circovirus Type 2 (PCV2) Vaccine players cover Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Porcine circovirus type 2 mainly causes multisystem failure disease characterized by generalized lymphadenopathy in pigs, clinically manifested as multisystem failure syndrome, porcine dermatitis and nephritic syndrome, and porcine respiratory disease syndrome in weaned piglets , sow reproductive disorders, necrotizing lymphadenitis, granulomatous enteritis and exudative epidermatitis, etc. The vaccine can significantly improve the production performance of pig farms, significantly increase the growth rate, survival rate and feed utilization rate of pigs at all stages, and significantly reduce the incidence of disease and death rate.
LPI (LP Information)’ newest research report, the “Porcine Circovirus Type 2 (PCV2) Vaccine Industry Forecast” looks at past sales and reviews total world Porcine Circovirus Type 2 (PCV2) Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Porcine Circovirus Type 2 (PCV2) Vaccine sales for 2023 through 2029. With Porcine Circovirus Type 2 (PCV2) Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Porcine Circovirus Type 2 (PCV2) Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Porcine Circovirus Type 2 (PCV2) Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Porcine Circovirus Type 2 (PCV2) Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Porcine Circovirus Type 2 (PCV2) Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Porcine Circovirus Type 2 (PCV2) Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Porcine Circovirus Type 2 (PCV2) Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Porcine Circovirus Type 2 (PCV2) Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
WH Type
LG Type
SH Type
SD Type
ZJ C Type
Others
Segmentation by application
Piglets
Adults Pigs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry
Key Questions Addressed in this Report
What is the 10-year outlook for the global Porcine Circovirus Type 2 (PCV2) Vaccine market?
What factors are driving Porcine Circovirus Type 2 (PCV2) Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Porcine Circovirus Type 2 (PCV2) Vaccine market opportunities vary by end market size?
How does Porcine Circovirus Type 2 (PCV2) Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Porcine Circovirus Type 2 (PCV2) Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Porcine Circovirus Type 2 (PCV2) Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Porcine Circovirus Type 2 (PCV2) Vaccine Segment by Type
2.2.1 WH Type
2.2.2 LG Type
2.2.3 SH Type
2.2.4 SD Type
2.2.5 ZJ C Type
2.2.6 Others
2.3 Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type
2.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Type (2018-2023)
2.4 Porcine Circovirus Type 2 (PCV2) Vaccine Segment by Application
2.4.1 Piglets
2.4.2 Adults Pigs
2.5 Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application
2.5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Application (2018-2023)
3 Global Porcine Circovirus Type 2 (PCV2) Vaccine by Company
3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Breakdown Data by Company
3.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Company (2018-2023)
3.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Company
3.4 Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Product Location Distribution
3.4.2 Players Porcine Circovirus Type 2 (PCV2) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Porcine Circovirus Type 2 (PCV2) Vaccine by Geographic Region
4.1 World Historic Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Growth
4.4 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Growth
4.5 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Growth
4.6 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Growth
5 Americas
5.1 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country
5.1.1 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023)
5.1.2 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023)
5.2 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type
5.3 Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region
6.1.1 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2018-2023)
6.1.2 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2018-2023)
6.2 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type
6.3 APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine by Country
7.1.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023)
7.1.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023)
7.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type
7.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine by Country
8.1.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type
8.3 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine
10.3 Manufacturing Process Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine
10.4 Industry Chain Structure of Porcine Circovirus Type 2 (PCV2) Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Porcine Circovirus Type 2 (PCV2) Vaccine Distributors
11.3 Porcine Circovirus Type 2 (PCV2) Vaccine Customer
12 World Forecast Review for Porcine Circovirus Type 2 (PCV2) Vaccine by Geographic Region
12.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size Forecast by Region
12.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Forecast by Region (2024-2029)
12.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Porcine Circovirus Type 2 (PCV2) Vaccine Forecast by Type
12.7 Global Porcine Circovirus Type 2 (PCV2) Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis Animal Health
13.1.1 Zoetis Animal Health Company Information
13.1.2 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Animal Health Main Business Overview
13.1.5 Zoetis Animal Health Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Ceva Santé Animale
13.4.1 Ceva Santé Animale Company Information
13.4.2 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.4.3 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ceva Santé Animale Main Business Overview
13.4.5 Ceva Santé Animale Latest Developments
13.5 MSD Animal Health
13.5.1 MSD Animal Health Company Information
13.5.2 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MSD Animal Health Main Business Overview
13.5.5 MSD Animal Health Latest Developments
13.6 SPAH
13.6.1 SPAH Company Information
13.6.2 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SPAH Main Business Overview
13.6.5 SPAH Latest Developments
13.7 Nanjing Tianbang Biological Technology
13.7.1 Nanjing Tianbang Biological Technology Company Information
13.7.2 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.7.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nanjing Tianbang Biological Technology Main Business Overview
13.7.5 Nanjing Tianbang Biological Technology Latest Developments
13.8 Sichuan Huapai Bio-pharmaceutical
13.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
13.8.2 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sichuan Huapai Bio-pharmaceutical Main Business Overview
13.8.5 Sichuan Huapai Bio-pharmaceutical Latest Developments
13.9 Guangdong Winsun Bio Pharmaceutical
13.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio Pharmaceutical Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Shanghai Hile Bio-Technology
13.11.1 Shanghai Hile Bio-Technology Company Information
13.11.2 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Hile Bio-Technology Main Business Overview
13.11.5 Shanghai Hile Bio-Technology Latest Developments
13.12 Harbin Pharmaceutical Group Bio-Vaccine
13.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
13.12.2 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Harbin Pharmaceutical Group Bio-Vaccine Main Business Overview
13.12.5 Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
13.13 Ringpu
13.13.1 Ringpu Company Information
13.13.2 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ringpu Main Business Overview
13.13.5 Ringpu Latest Developments
13.14 Shandong Huahong Bioengineering
13.14.1 Shandong Huahong Bioengineering Company Information
13.14.2 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shandong Huahong Bioengineering Main Business Overview
13.14.5 Shandong Huahong Bioengineering Latest Developments
13.15 Weike Biotechnology
13.15.1 Weike Biotechnology Company Information
13.15.2 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Weike Biotechnology Main Business Overview
13.15.5 Weike Biotechnology Latest Developments
13.16 Nanjing Tianbang Biological Technology
13.16.1 Nanjing Tianbang Biological Technology Company Information
13.16.2 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Nanjing Tianbang Biological Technology Main Business Overview
13.16.5 Nanjing Tianbang Biological Technology Latest Developments
13.17 China Animal Husbandry Industry
13.17.1 China Animal Husbandry Industry Company Information
13.17.2 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
13.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 China Animal Husbandry Industry Main Business Overview
13.17.5 China Animal Husbandry Industry Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Porcine Circovirus Type 2 (PCV2) Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of WH Type
Table 4. Major Players of LG Type
Table 5. Major Players of SH Type
Table 6. Major Players of SD Type
Table 7. Major Players of ZJ C Type
Table 8. Major Players of Others
Table 9. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 10. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
Table 11. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2018-2023) & ($ million)
Table 12. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2018-2023)
Table 13. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2018-2023)
Table 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2018-2023)
Table 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2018-2023)
Table 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Company (2018-2023) & (K Doses)
Table 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Company (2018-2023)
Table 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Company (2018-2023)
Table 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 24. Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Producing Area Distribution and Sales Area
Table 25. Players Porcine Circovirus Type 2 (PCV2) Vaccine Products Offered
Table 26. Porcine Circovirus Type 2 (PCV2) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 30. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share Geographic Region (2018-2023)
Table 31. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 34. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country/Region (2018-2023)
Table 35. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 38. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2018-2023)
Table 39. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2018-2023)
Table 41. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 42. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 43. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2018-2023) & (K Doses)
Table 44. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2018-2023)
Table 45. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2018-2023)
Table 47. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 48. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 49. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 50. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2018-2023)
Table 51. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2018-2023)
Table 53. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 54. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 55. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 56. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 60. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 61. Key Market Drivers & Growth Opportunities of Porcine Circovirus Type 2 (PCV2) Vaccine
Table 62. Key Market Challenges & Risks of Porcine Circovirus Type 2 (PCV2) Vaccine
Table 63. Key Industry Trends of Porcine Circovirus Type 2 (PCV2) Vaccine
Table 64. Porcine Circovirus Type 2 (PCV2) Vaccine Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Porcine Circovirus Type 2 (PCV2) Vaccine Distributors List
Table 67. Porcine Circovirus Type 2 (PCV2) Vaccine Customer List
Table 68. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 73. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 77. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 79. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 81. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Zoetis Animal Health Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 84. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 85. Zoetis Animal Health Main Business
Table 86. Zoetis Animal Health Latest Developments
Table 87. Boehringer-Ingelheim Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 89. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 90. Boehringer-Ingelheim Main Business
Table 91. Boehringer-Ingelheim Latest Developments
Table 92. Merck Animal Health Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 94. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 95. Merck Animal Health Main Business
Table 96. Merck Animal Health Latest Developments
Table 97. Ceva Santé Animale Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 99. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 100. Ceva Santé Animale Main Business
Table 101. Ceva Santé Animale Latest Developments
Table 102. MSD Animal Health Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 104. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 105. MSD Animal Health Main Business
Table 106. MSD Animal Health Latest Developments
Table 107. SPAH Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 109. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 110. SPAH Main Business
Table 111. SPAH Latest Developments
Table 112. Nanjing Tianbang Biological Technology Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 114. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 115. Nanjing Tianbang Biological Technology Main Business
Table 116. Nanjing Tianbang Biological Technology Latest Developments
Table 117. Sichuan Huapai Bio-pharmaceutical Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 119. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 120. Sichuan Huapai Bio-pharmaceutical Main Business
Table 121. Sichuan Huapai Bio-pharmaceutical Latest Developments
Table 122. Guangdong Winsun Bio Pharmaceutical Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 124. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 125. Guangdong Winsun Bio Pharmaceutical Main Business
Table 126. Guangdong Winsun Bio Pharmaceutical Latest Developments
Table 127. Wuhan Keqian Biology Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 129. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 130. Wuhan Keqian Biology Main Business
Table 131. Wuhan Keqian Biology Latest Developments
Table 132. Shanghai Hile Bio-Technology Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 134. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 135. Shanghai Hile Bio-Technology Main Business
Table 136. Shanghai Hile Bio-Technology Latest Developments
Table 137. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 139. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 140. Harbin Pharmaceutical Group Bio-Vaccine Main Business
Table 141. Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
Table 142. Ringpu Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 144. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 145. Ringpu Main Business
Table 146. Ringpu Latest Developments
Table 147. Shandong Huahong Bioengineering Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 149. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 150. Shandong Huahong Bioengineering Main Business
Table 151. Shandong Huahong Bioengineering Latest Developments
Table 152. Weike Biotechnology Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 154. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 155. Weike Biotechnology Main Business
Table 156. Weike Biotechnology Latest Developments
Table 157. Nanjing Tianbang Biological Technology Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 159. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 160. Nanjing Tianbang Biological Technology Main Business
Table 161. Nanjing Tianbang Biological Technology Latest Developments
Table 162. China Animal Husbandry Industry Basic Information, Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolios and Specifications
Table 164. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 165. China Animal Husbandry Industry Main Business
Table 166. China Animal Husbandry Industry Latest Developments
List of Figures
Figure 1. Picture of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 2. Porcine Circovirus Type 2 (PCV2) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of WH Type
Figure 10. Product Picture of LG Type
Figure 11. Product Picture of SH Type
Figure 12. Product Picture of SD Type
Figure 13. Product Picture of ZJ C Type
Figure 14. Product Picture of Others
Figure 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type in 2022
Figure 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2018-2023)
Figure 17. Porcine Circovirus Type 2 (PCV2) Vaccine Consumed in Piglets
Figure 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market: Piglets (2018-2023) & (K Doses)
Figure 19. Porcine Circovirus Type 2 (PCV2) Vaccine Consumed in Adults Pigs
Figure 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market: Adults Pigs (2018-2023) & (K Doses)
Figure 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2022)
Figure 22. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application in 2022
Figure 23. Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market by Company in 2022 (K Doses)
Figure 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Company in 2022
Figure 25. Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Company in 2022
Figure 27. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2018-2023 (K Doses)
Figure 30. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2018-2023 (K Doses)
Figure 32. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2018-2023 (K Doses)
Figure 34. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country in 2022
Figure 38. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country in 2022
Figure 39. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
Figure 40. Americas Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2018-2023)
Figure 41. United States Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region in 2022
Figure 46. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Regions in 2022
Figure 47. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
Figure 48. APAC Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2018-2023)
Figure 49. China Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country in 2022
Figure 57. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country in 2022
Figure 58. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
Figure 59. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2018-2023)
Figure 60. Germany Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine in 2022
Figure 75. Manufacturing Process Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 76. Industry Chain Structure of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のブタサーコウイルス2型（PCV2）ワクチン市場予測 2023年-2029年] (コード：LP23DC08452)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のブタサーコウイルス2型（PCV2）ワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の豚サーコウイルスワクチン市場予測2023-2029：遺伝子組み換えワクチン、死菌ワクチン
  • 世界の動物インフルエンザワクチン市場予測 2023年-2029年
  • 世界の豚連鎖球菌ワクチン市場予測 2023年-2029年
  • 世界の牛疫ウイルスワクチン市場予測 2023年-2029年
  • 世界のウシロタウイルスワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆